The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy
Abstract
Hypertension resistant to 2 antihypertensive drugs is more common among obese patients than among lean patients. The case we describe and the observations we report suggest that refractoriness among obese hypertensives is frequently caused by obstructive sleep apnea and/or inappropriately high plasma aldosterone levels. In other words, obese hypertensives may have sleep apnea, obese hypertensives without sleep apnea may have inappropriately elevated levels of plasma aldosterone, and a surprising number of obese patients with sleep apnea also have elevated levels of aldosterone. The mechanisms by which obesity and obstructive sleep apnea increase aldosterone levels and raise blood pressure are not understood, but sympathetic nervous system activation and production of nonclassical adrenal stimuli are two possibilities. Obstructive sleep apnea can be detected with a careful history and various sleep studies. Inappropriately elevated aldosterone levels can be detected by measuring the ratio of plasma aldosterone concentration to plasma renin activity. Successful treatment of these resistant hypertensives often can be achieved by devices that provide positive pressure to the upper airway to correct obstructive sleep apnea and by incorporating an aldosterone antagonist in the therapeutic regimen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, obesity is a major risk factor for resistant hypertension, i.e. patients who have uncontrolled blood pressure despite being on three or more antihypertensive medications (7;8).”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Reaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435
Keaney, J. F., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000058402.34138.11 · Cited by 1,304
Regional adiposity and morbidity.
Kissebah, A. H., & Krakower, G. R. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.4.761 · Cited by 1,132
Cushman, W. C., Ford, C. E., Cutler, J. A., Margolis, K. L., Davis, B. R., Grimm, R. H., Black, H. R., Hamilton, B. P., Holland, J., Nwachuku, C., et al. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.02045.x · Cited by 979
Population-Based Study of Sleep-Disordered Breathing as a Risk Factor for Hypertension
Young, T. B. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360178019 · Cited by 967
Research works printed but not linked: 7
Cited by
Sorted by citations
Items 201–276 of 276
Dong, J., Chen, X., Xiao, Y., Zhang, R., Niu, X., & Kong, W. (2015) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-015-1469-3 · Cited by 4
Waeber, B., Brunner, H.-R., Burnier, M., & Cohn, J. N. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_89 · Cited by 4
The Adrenergic Nervous System Conversing With the Adrenal Cortex
Pratt, J. H. (2006) · Hypertension · doi:10.1161/01.hyp.0000244561.84382.df · Cited by 4
Approach to a case of secondary hypertension
Garg, N., Bhatia, T., & Jaiswal, A. K. (2013) · Clinical Queries Nephrology · doi:10.1016/j.cqn.2013.04.004 · Cited by 3
Hypertension: From Epidemiology to Therapeutics
Velasco, M., & Israili, Z. H. (2012) · International Journal of Hypertension · doi:10.1155/2012/908431 · Cited by 3
Balderrábano-Saucedo, N., del Rio, B., Navarrete-Rodriguez, E. M., Berber, A. C., & Méndez, N. (2015) · Cardiology in the Young · doi:10.1017/s1047951115001298 · Cited by 3
Sołtysiak, M., Miazgowski, T., Jaroszyńska, E., Janowska, A., & Widecka, K. (2015) · Arterial Hypertension · doi:10.5603/ah.2015.0003 · Cited by 3
Cardiovascular-derived therapeutic peptidomimetics in cardiovascular disease
Litmanovich, A., Moady, G., Saad, M., Blumberg, Y., Ertracht, O., & Qvit, N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820141-1.00011-x · Cited by 3
Childhood Hypertension: Epidemiology, Etiology, Target Organ Damage, and Consequences
Lurbe, E., & Simonetti, G. D. (2016) · Springer eBooks · doi:10.1007/978-3-662-52972-0_49 · Cited by 3
Resistant Hypertension: Neurohumoral Aspects
Rossi, G. P. (2013) · Springer eBooks · doi:10.1007/978-88-470-5415-8_2 · Cited by 2
Belly fat and resistant hypertension
Jordan, J., & Grassi, G. M. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328339b8d9 · Cited by 2
DEPRESSION ASSOCIATED CO-MORBID CARDIOVASCULAR AND METABOLIC COMPLICATIONS
Radhakrishnan, M., Devadoss, T., Dilip, P., Gautam, B., Jindal, A., & Bhatt, S. (2010) · Cited by 2
Alsedairy, S., Albadr, N. A., Bekhaeit, Z., Binobead, M., Aldubaykhi, H., & Aljurbua, T. (2018) · Novel Techniques in Nutrition & Food Science · doi:10.31031/ntnf.2018.02.000538 · Cited by 3
[Progress in clinical research of REM-related obstructive sleep apnea].
Zhang, X., Li, X., Chen, G., & Ge, Y. (2022) · PubMed Central · doi:10.13201/j.issn.2096-7993.2022.02.015 · Cited by 2
Elliott, W. J. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50062-3 · Cited by 2
Obesity and Hypertension: Etiology and the Effects of Diet, Bariatric Surgery, and Antiobesity Drugs
Elattar, S., Chand, S., Salem, A. M., Abdulfattah, A., Bassiony, M. A. A., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000937 · Cited by 1
Paragano, A. J., Machado, R. A., Abdala, A., Cordero, D. J., Angel, A., Grasiosi, J. C., Magallanes, C. H., & Esper, R. J. (2025) · Revista Argentina de Cardiología · doi:10.7775/rac.v77i4.2383 · Cited by 1
Low fiber intake increase risk of Diabetes mellitus in overweight people
Permanasari, Y., & Rachmawati, R. (2012) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.22435/hsji.v2i1 · Cited by 1
Primary Aldosteronism: Molecular Mechanisms and Diagnosis
Rossi, G. P., & Lenzini, L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_1 · Cited by 1
Importancia de la presión arterial diastólica en relación con la edad
Franklin, S. S. (2007) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(07)71692-6 · Cited by 1
Resistant hypertension: a dangerous and challenging clinical situation
O’Connell, J. L., Guedes, N. R., Farina, P. H. R., Silva, G., Roever, L., & de Almeida, R. P. (2019) · MOJ Gerontology & Geriatrics · doi:10.15406/mojgg.2019.04.00207 · Cited by 1
Lin, E. A., Barlow, G. M., & Mathur, R. (2015) · Endocrine updates · doi:10.1007/978-1-4939-2146-1_2 · Cited by 1
Majewski, C., & Bakris, G. L. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_5-2 · Cited by 1
Differential Gene Expression Profile in Essential Hypertension
Yang, P. (2012) · InTech eBooks · doi:10.5772/29645 · Cited by 1
Apneia do sono e hipertensão arterial sistêmica Sleep apnea and systemic arterial hypertension
Pedrosa, R. P., Cabral, M. M., Pedrosa, L. D. C., Celestino, D., Filho, S., & Lorenzi‐Filho, G. (2009) · Cited by 1
Franklin, S. S. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50056-8 · Cited by 1
Sympathetic vascular tone in human obesity
Correia, M. (2007) · doi:10.17077/etd.v54kf0if · Cited by 1
Hiperaldosteronismo primario subclínico
Pérez, S. C. (2004) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(04)71828-0 · Cited by 1
Evaluation and Treatment of Hypertension
Nguyen, Q. P. H., & Plodkowski, R. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_14 · Cited by 1
Setaro, J. F. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3053-9.50049-4 · Cited by 1
Calhoun, D. A. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0258-5.50149-6 · Cited by 1
Self-citationAldosterone and Cardiovascular Diseases
Tomaschitz, A., & Pilz, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_12
Pimenta, E. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.98.2012.tde-07122012-113447
Hipertensión arterial resistente al tratamiento
Olivieri, A. O., Akopian, M., Manglano, X., & Feldstein, C. A. (2007) · Redalyc (Universidad Autónoma del Estado de México)
From Abdominal Adiposity to Hypertension: Mechanisms and Clinical Implications
Rocchini, A. P. (2011) · Wiley eBooks · doi:10.1002/9781444318456.ch33
Endo, Y., Serizawa, F., Kato, T., Toyama, H., Ejima, Y., Sato, A., Kurosawa, S., Hasegawa, Y., Hida, W., & Matsubara, M. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2011.577482
INCREASE IN TREATMENT-REFRACTORY HYPERTENSION: PROGRESS IN CURRENT TREATMENT BY PRIMARY CARE
Egan, B. M. (2011) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2011.09.004
Burnier, M. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.07.008
Prevalence and Association of Hypertension with the Different Components of the Metabolic Syndrome
Paragano, A. J., Machado, R. A., Abdala, A., Cordero, D. J., Ángel, A., Grasiosi, J. C., Magallanes, C. H., Esper, R. J., & Coronado, M. (2009)
Black, H. R. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.12.006
For information on reprint requests of more than 101 and commercial reprints contact
Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Edwards, H. A. (2008)
Rossi, G. P., Seccia, T. M., & Caielli, P. (2012) · Springer eBooks · doi:10.1007/978-88-470-2601-8_4
Title: Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An
Funder, J. W., Carey, R. M., Fardella, C., Gómez-Sánchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008)
Pimentel, A., Cabrita, A., Jerónimo, T. M., Ministro, A., Bernardo, I., & Neves, P. L. (2014)
Clinical condition of metabolic syndrome. 3 Metabolic syndrome and aldosterone
長瀬, 美., & 藤田, 敏. (2006) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.95.1726
Bahmad, F. (2011) · InTech eBooks · doi:10.5772/1506
Obstructive sleep apnea and hypertension: Interactions and clinical implications
Kapa, S., Gami, A. S., & Somers, V. K. (2011) · Informa Healthcare eBooks · doi:10.3109/9781420020885.011
Davy, K. P., & Gentile, C. L. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50042-8
Hipertensão arterial secundária
Rodrigues, C. J. D. O., & Tavares, A. (2007) · DOAJ (DOAJ: Directory of Open Access Journals)
Hypertension in the Dialysis Patient
Sinha, A. D. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6436-9_7
Shafer, B. M., Hargens, T. A., Aron, A., Newsome, L. J., Edwards, E. S., & Womack, C. J. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000494307.19717.cb
Normal HPA Axis and Rhythm, Exemplary Sleep Disorders
Buckley, T. M., Schatzberg, A. F., & Sleep, S. (2005)
Sleep Disturbances/Sleep Apnea
Parati, G., Lombardi, C., Narkiewicz, K., Wolf, J., & Ochoa, J. E. (2017) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_18
Majewski, C., & Bakris, G. L. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_5-1
Friedman, O. (2010) · TSpace (University of Toronto)
The Role of Perivascular Fat in Raising Blood Pressure in Obesity and Diabetes
Aghamohammadzadeh, R., & Heagerty, A. M. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-75310-2_20
Acelajado, M. C., & Calhoun, D. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0101-8.00031-x
Self-citationThe pathophysiology of obesity hypoventilation syndrome
Tulaimat, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815290-4.00007-5
Pathophysiological Mechanisms Implicated in Organ Damage and Cardiovascular Events
Aghamohammadzadeh, R., & Heagerty, A. M. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-47801-8_14
Integrating Health and Energy Efficiency in Multi-Family Buildings
Rotondo, J., Energy Efficiency Office. Federal Energy Management Program Office USDOE Office of Energy Efficiency and Renewable Energy (EERE), Keene, K., & Wang, N. (2020) · doi:10.2172/1646977
Hypertonie und Ernährung: Positionspapier der Österreichischen Gesellschaft für Ernährung (ÖGE)
Dorner, T. E., Genser, D., Krejs, G. J., Slany, J., Watschinger, B., Ekmekçioğlu, C., & Rieder, A. (2013) · Herz
Majewski, C., & Bakris, G. L. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_5
Parati, G., Lombardi, C., & Ochoa, J. E. (2016) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-34141-5_5
Majewski, C., & Bakris, G. L. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_5
Flynn, C. A., & Bakris, G. L. (2014) · Springer eBooks · doi:10.1007/978-3-7091-0715-7_49
Harbuz-Miller, I., Woodman, R., & Lastra, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95896-3
Importancia de la presión arterial diastólica en relación con la edad
Franklin, S. S. (2007) · Hipertensión · doi:10.1016/s0212-8241(07)72451-9
Saleh, A., & Ebsat, A. (2024) · The Scientific Journal of University of Benghazi · doi:10.37376/sjuob.v37i1.5947
Association between Sleep Duration and Hypertension in Middle-Aged and Elderly Chinese
王, 琅. (2025) · Nursing Science · doi:10.12677/ns.2025.141024
Yetim, A. I., Gökler, C., Turan, Ü., Aydede, Y. S., Yugruk, A., Yener, K., & Kilic, V. (2026) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-025-04253-3
Endocrine hypertension in 2025: how AI and multiomics are revolutionizing detection
Fuentes‐Mendoza, J. M., Concepción‐Zavaleta, M. J., Mendoza-Godoy, J. J., Aldave, J. E. Q., Morón-Siguas, J. C., & Paz‐Ibarra, J. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2634025
de Souza, N. P. P. (2007) · Aleph UCLA Undergraduate Research Journal for the Humanities and Social Sciences
PERIVASCULAR ADIPOSE TISSUE AND VESSEL CONTRACTILITY IN HEALTH AND OBESITY
Aghamohammadzadeh, R. (2014) · Research Explorer (The University of Manchester)
Metadata
- Authors
- Goodfriend, T. L., & Calhoun, D. A.
- Affiliations
- University of Wisconsin–Madison (US)
- ORCID
- Calhoun, David A.
- Venue
- Hypertension
- Published
- 2004-03
- Volume
- 43
- Issue
- 3
- Pages
- 518-524
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2114339665
- Cited by
- 279
- References
- 61
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 9 · 2021: 3 · 2020: 7 · 2019: 12 · 2018: 11 · 2017: 11 · 2016: 6 · 2015: 14 · 2014: 27 · 2013: 11 · 2012: 21
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- resistant hypertension, obesity, obstructive sleep apnea, plasma aldosterone, aldosterone-renin ratio, sympathetic activation, mineralocorticoid receptor antagonists, blood pressure regulation
- MeSH terms
- Aldosterone, Antihypertensive Agents, Drug Resistance, Humans, Hypertension, Male, Middle Aged, Models, Theoretical, Obesity, Sleep Apnea Syndromes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review